Globus Medical (GMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Globus Medical (GMED) has a cash flow conversion efficiency ratio of 0.054x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($248.59 Million) by net assets ($4.57 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Globus Medical - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Globus Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GMED current and long-term liabilities for a breakdown of total debt and financial obligations.
Globus Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Globus Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bajaj Holdings & Investment Limited
NSE:BAJAJHLDNG
|
-0.047x |
|
Julius Baer Gruppe AG
SW:BAER
|
0.767x |
|
Anhui Conch Cement Co Ltd
SHG:600585
|
0.013x |
|
GD Power Development Co Ltd
SHG:600795
|
0.123x |
|
Kuang Chi Technologies Co Ltd
SHE:002625
|
0.007x |
|
Bollore SA
PA:BOL
|
-0.109x |
|
Xpeng Inc
NYSE:XPEV
|
0.004x |
|
Var Energi ASA
OL:VAR
|
36.298x |
Annual Cash Flow Conversion Efficiency for Globus Medical (2010–2025)
The table below shows the annual cash flow conversion efficiency of Globus Medical from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see GMED company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.57 Billion | $753.45 Million | 0.165x | +32.19% |
| 2024-12-31 | $4.18 Billion | $520.64 Million | 0.125x | +104.63% |
| 2023-12-31 | $4.00 Billion | $243.50 Million | 0.061x | -36.99% |
| 2022-12-31 | $1.85 Billion | $178.47 Million | 0.097x | -39.07% |
| 2021-12-31 | $1.74 Billion | $276.27 Million | 0.159x | +20.21% |
| 2020-12-31 | $1.51 Billion | $198.79 Million | 0.132x | +7.63% |
| 2019-12-31 | $1.40 Billion | $171.97 Million | 0.123x | -19.97% |
| 2018-12-31 | $1.19 Billion | $181.64 Million | 0.153x | -7.05% |
| 2017-12-31 | $967.78 Million | $159.53 Million | 0.165x | -20.20% |
| 2016-12-31 | $832.08 Million | $171.89 Million | 0.207x | +21.17% |
| 2015-12-31 | $715.32 Million | $121.96 Million | 0.170x | +26.07% |
| 2014-12-31 | $585.45 Million | $79.17 Million | 0.135x | -31.66% |
| 2013-12-31 | $472.36 Million | $93.47 Million | 0.198x | -0.05% |
| 2012-12-31 | $386.50 Million | $76.52 Million | 0.198x | -26.81% |
| 2011-12-31 | $282.48 Million | $76.41 Million | 0.271x | -13.41% |
| 2010-12-31 | $228.19 Million | $71.29 Million | 0.312x | -- |
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more